Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aerovate Therapeutics Inc AVTE

Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension (PAH), a devastating disease impacting approximately 70... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:AVTE)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders

Accesswire 11 days ago

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of BMTX, AVTE, ALTR and PFIE

Accesswire 11 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, MPB, AVTE on Behalf of Shareholders

PR Newswire November 8, 2024

Lifshitz Law PLLC Announces Investigations of ATSG, STAF, MPB, and AVTE

Accesswire November 7, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders

PR Newswire November 5, 2024

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE

Business Wire November 4, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. - AVTE

PR Newswire November 3, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders

PR Newswire November 1, 2024

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm

PR Newswire November 1, 2024

Opinion & Analysis (NDAQ:AVTE)

No current opinion is available.

Bullboard Posts (NDAQ:AVTE)

Aerovate Therapeutics to Explore Strategic Alternatives

Breaking News: $AVTE Aerovate Therapeutics to Explore Strategic AlternativesWALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate...
whytestocks - July 8, 2024

Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announ

NEWS: $AVTE Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC | BenzingaATLANTA, June 21, 2024 ...
whytestocks - June 21, 2024

Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics

Just In: $AVTE Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday? | BenzingaMonday, Aerovate...
whytestocks - June 17, 2024